Boryung Pharm Working Capital to Net Assets Ratio
Boryung Pharm working capital to net assets ratio. Boryung Pharm (003850) has a Working Capital to Net Assets ratio of 43.3% as of September 2025. Working capital of ₩354.38 Billion (current assets of ₩609.34 Billion minus current liabilities of ₩254.96 Billion) is measured against net assets of ₩818.35 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check 003850 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Boryung Pharm (2009–2024)
Working capital to net assets ratio of Boryung Pharm from 2009 to 2024. This chart shows how Boryung Pharm's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2009 to 2024. As of September 2025, the ratio stands at 43.3%, reflecting working capital of ₩354.38 Billion against net assets of ₩818.35 Billion KRW. See Boryung Pharm (003850) defensive interval to measure how many days the company can operate on defensive assets alone.
Boryung Pharm Working Capital to Net Assets Ratio by Year (2009–2024)
Boryung Pharm working capital to net assets ratio by year from 2009 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Boryung Pharm from 2009 to 2024, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see how large is Boryung Pharm's balance sheet.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 50.0% | ₩392.23 Billion | ₩784.50 Billion | ₩631.57 Billion | ₩239.34 Billion | ▲ +17.8 pp |
| 2023 | 32.1% | ₩176.58 Billion | ₩549.25 Billion | ₩377.66 Billion | ₩201.08 Billion | ▲ +20.4 pp |
| 2022 | 11.8% | ₩60.90 Billion | ₩516.42 Billion | ₩338.38 Billion | ₩277.48 Billion | ▼ -47.5 pp |
| 2021 | 59.3% | ₩281.36 Billion | ₩474.31 Billion | ₩437.31 Billion | ₩155.95 Billion | ▲ +2.7 pp |
| 2020 | 56.7% | ₩192.79 Billion | ₩340.29 Billion | ₩315.66 Billion | ₩122.87 Billion | ▲ +23.9 pp |
| 2019 | 32.7% | ₩92.64 Billion | ₩282.95 Billion | ₩231.85 Billion | ₩139.21 Billion | ▼ -4.3 pp |
| 2018 | 37.0% | ₩94.81 Billion | ₩256.10 Billion | ₩224.55 Billion | ₩129.74 Billion | ▼ -8.0 pp |
| 2017 | 45.0% | ₩112.34 Billion | ₩249.65 Billion | ₩228.54 Billion | ₩116.20 Billion | ▲ +23.2 pp |
| 2016 | 21.8% | ₩42.50 Billion | ₩195.35 Billion | ₩238.11 Billion | ₩195.61 Billion | ▼ -11.1 pp |
| 2012 | 32.8% | ₩47.83 Billion | ₩145.79 Billion | ₩157.89 Billion | ₩110.05 Billion | ▲ +1.7 pp |
| 2011 | 31.1% | ₩42.89 Billion | ₩137.97 Billion | ₩149.73 Billion | ₩106.84 Billion | ▼ -1.7 pp |
| 2010 | 32.8% | ₩44.68 Billion | ₩136.41 Billion | ₩138.67 Billion | ₩93.99 Billion | ▼ -17.7 pp |
| 2009 | 50.5% | ₩62.59 Billion | ₩124.01 Billion | ₩107.36 Billion | ₩44.77 Billion | — |